Document Detail


Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
MedLine Citation:
PMID:  17403076     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: With conventional methods of endoscopic mucosal resection for early gastric cancer (EGC), proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs) have a similar effect on preventing bleeding from artificial ulcers. An objective of this study is to investigate whether a stronger acid suppressant (i.e., PPI) more effectively prevents bleeding after the recent advanced technique of endoscopic submucosal dissection (ESD) for EGC.
METHODS: This was a prospective randomized controlled trial performed in a referral cancer center. A total of 143 patients with EGC who underwent ESD were randomly assigned to the treatment groups. They received either rabeprazole 20 mg (PPI group) or cimetidine 800 mg (H2RA group) on the day before ESD and continued for 8 wk. The primary end point was the incidence of bleeding that was defined as hematemesis or melena that required endoscopic hemostasis and decreased the hemoglobin count by more than 2 g/dL.
RESULTS: In baseline data, the endoscopists who performed the ESD were significantly different between the groups. Finally, 66 of 73 patients in the PPI group and 64 of 70 in the H2RA group were analyzed. Bleeding occurred in four patients in the PPI group and 11 in the H2RA group (P= 0.057). Multivariate analysis revealed that treatment with the PPI significantly reduced the risk of bleeding: adjusted hazard ratio 0.47, 95% confidence interval 0.22-0.92, P= 0.028. One delayed perforation was experienced in the H2RA group.
CONCLUSIONS: PPI therapy more effectively prevented delayed bleeding from the ulcer created after ESD than did H2RA treatment.
Authors:
Noriya Uedo; Yoji Takeuchi; Takuya Yamada; Ryu Ishihara; Hideharu Ogiyama; Sachiko Yamamoto; Motohiko Kato; Koichi Tatsumi; Eriko Masuda; Chie Tamai; Shunsuke Yamamoto; Koji Higashino; Hiroyasu Iishi; Masaharu Tatsuta
Related Documents :
25226516 - Symptoms of anxiety and depression are associated with satisfaction with information pr...
16484966 - Diagnostic approach to gastro-oesophageal reflux disease.
25161816 - Self-reported immature defense style as a predictor of outcome in short-term and long-t...
25300676 - First validation of a spanish-translated version of the edinburgh postnatal depression ...
19852326 - Compliance towards methadone maintenance therapy and its associated factors in selangor...
17937566 - Differences in symptom scores and health outcomes in premenstrual syndrome.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2007-03-31
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  102     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-08-09     Completed Date:  2007-09-14     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1610-6     Citation Subset:  IM    
Affiliation:
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use*
Adult
Aged
Aged, 80 and over
Anti-Ulcer Agents / therapeutic use*
Cimetidine / therapeutic use*
Female
Gastroscopy
Histamine H2 Antagonists / therapeutic use*
Humans
Male
Middle Aged
Multivariate Analysis
Peptic Ulcer Hemorrhage / etiology,  prevention & control*
Postoperative Complications
Prospective Studies
Proton Pumps / antagonists & inhibitors*
Stomach Neoplasms / surgery*
Chemical
Reg. No./Substance:
0/2-Pyridinylmethylsulfinylbenzimidazoles; 0/Anti-Ulcer Agents; 0/Histamine H2 Antagonists; 0/Proton Pumps; 32828355LL/rabeprazole; 51481-61-9/Cimetidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Insulated-tip knife endoscopic mucosal resection of large colorectal polyps unsuitable for standard ...
Next Document:  Endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular ...